Navigation Links
Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
Date:6/1/2010

SAN DIEGO, June 1 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.

"We are pleased the FDA has accepted our NDA for filing and look forward to working with the Agency during the review process," said Michael Narachi, President and CEO of Orexigen. "If approved, we believe Contrave will become an important therapeutic option for obese patients, making weight loss and weight maintenance an achievable cornerstone in the treatment of obesity and its common co-morbidities."

About the COR Phase 3 Program

All four trials in the COR Phase 3 program (COR-I, COR-II, COR-BMOD and COR- Diabetes) were randomized, double-blind, placebo-controlled trials. The co-primary endpoints were the proportion of patients achieving at least 5% weight loss and percent change in body weight compared to placebo.  Secondary endpoints included multiple measures of cardiometabolic risk, quality of life, control of eating, and glycemic control.

About Contrave

Contrave is an investigational combination therapy believed to address both physiological and behavioral drivers of obesity. The two components of this combination therapy
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers
2. Logical Therapeutics Secures $16.9M Series C Financing Round
3. Sorrento Therapeutics Awarded NIH Grant for MRSA Program
4. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
5. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
6. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
7. Orexigen(R) Therapeutics Schedules May 10, 2010 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2010
8. Osseon Therapeutics Demonstrates to the European Medical Community How to Think Outside The Balloon When Treating Vertebral Compression Fractures
9. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
10. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
11. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015  DICOM Grid,  the #1 medical ... was recognized as a semifinalist for a Minnie ... The awards are sponsored by Auntminnie.com, a comprehensive ... the medical imaging industry.  Since 1999, the "Minnies" ... acknowledge the contributions of their peers. Nominations are ...
(Date:8/31/2015)... -- Thousands of people will peacefully demonstrate their frustration ... epidemic at dozens of rallies across the country today. ... the United States has experienced skyrocketing rates ... heroin, yet the President has never once spoken publicly ... to President Obama , rally organizers compared his failure ...
(Date:8/31/2015)... The Wolf Administration today announced 289 drug ... State Police and local police departments have ... Heroin and opioid overdose are the leading cause of ... more individuals than those involved in fatal motor vehicle ... drug overdose. " Pennsylvania ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3
... Business Leaders, European Schoolnet and the European ... science and maths European business leaders and ... to inspire students to study science at university - ... is to recover and flourish by 2020. ...
... CAMBRIDGE, Mass., Dec. 13, 2011  Merrimack Pharmaceuticals, Inc. ... dosed in a Phase 1 clinical study combining ... ErbB3, with cetuximab (Erbitux®) and irinotecan (Camptosar®) in ... http://photos.prnewswire.com/prnh/20100913/NE63515LOGO ) The Phase 1 ...
Cached Medicine Technology:No European Scientists Left by 2020? 2No European Scientists Left by 2020? 3No European Scientists Left by 2020? 4Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The Bay ... to Veterans residing across southwest Florida by hiring more doctors and nurses and expanding ... of expanded services. , In early July, Dr. Anthony Jabre was selected to lead ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Replacement Surgery Program at Monmouth, was one of the first doctors in the ... results of this new approach have been impressive: faster recovery, decreased immediate and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Stewart Shofner ... be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose amblyopia. ... cause of visual impairment among children, affecting approximately 2 to 3 out of every ...
(Date:8/31/2015)... ... 31, 2015 , ... The dental implant and prosthetic market in the U.S. ... Dentistry. (See Press Room ) More than 30 million Americans are missing all ... increasing demand for dental implants, the National Association of Dental Laboratories (NADL) created the ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... Technology Studies (InHealth) has awarded $1.7 million in grants ... Hopkins University, Northwestern University, Medical College of Georgia, Tufts ... funding allows scientists to examine the economic and social ... diseases and chronic medical conditions. , Researchers ...
... Ribbon Week Will Educate Parents about Prescription,Drug Abuse, ... designated Monday, October 27th as the first "Lock Your ... Week from October 27-31, to,raise awareness and provide parents ... Statistics show that over 3 million teens in the ...
... In light of,recent events impacting the global ... ), a publicly traded special purpose,acquisition company with ... assets being held in trust. As of October ... account at Morgan Stanley, with,Continental Transfer & Trust ...
... NEW YORK, Oct. 14 On the eve of ... a Call for,Endorsement of National Latino AIDS Awareness Day ... the commitment of the future President of,the United States ... of,Hispanics throughout the United States and Puerto Rico," stated ...
... John Price, an Influential ... for More Than 50 Years, PLEASANT HILL, Calif., Oct. 14 ... Gala on Friday, October 17, 2008 at,the Diablo Country Club located ... of community service the Y has provided,throughout Contra Costa County. One ...
... AMSTERDAM, Netherlands, Oct. 14 Doctors in,the Netherlands ... VAR ) to treat four early stage ... among the world,s first treatments of their kind. ... plan to replace,conventional stereotactic radiotherapy treatments with RapidArc ...
Cached Medicine News:Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 2Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 3Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 4Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Apex Bioventures Announces Trust Investment Details 2Health News:The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15 2Health News:Mt. Diablo Region YMCA to Celebrate 50 Years of Community Service at 28th Annual Boosters Gala on October 17, 2008 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 3
... new OTI-Scan 1000 is the most advanced ... B/A-scan system operates with a single Macintosh ... B-scans with a streamlined internal probe rotator. ... newly designed. The UltraFast 12 MHz B-probe ...
... The B5500 is a sensitive B-scan system ... the axial length of both eyes differ by ... ocular abnormality must be suspected. The B5500 enables ... setting up a water bath or inserting shells ...
... A-scan and B-scan system, providing accurate and ... high frequency, low noise probe and fast ... upon application of the probe along the ... length of both eyes differ by more ...
... The CineScan A/B represent a true breakthrough ... image with technology and diagnostic capability previously ... the vitreous. Adjust the gain up to ... be invisible at a standard 90db setting ...
Medicine Products: